Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30930714 | 0.91 | POLB (0.50) | ALDH1A1ALOX15KMT2AAPEX1CYP1A2 | |
| SCHEMBL11700974 | 0.81 | ALDH1A1 (0.71) | ALDH1A1ALOX15KMT2AAPEX1CYP1A2 | |
| SCHEMBL9849005 | 0.81 | AKR1C3 (0.61) | ALDH1A1KMT2AGAAMAPTMEN1 | |
| SCHEMBL4121945 | 0.80 | KDM4E (0.50) | ALDH1A1KMT2AGAAMAPTPOLB | |
| Phthalic Acid SCHEMBL1686043 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E | |
| Phthalic Acid SCHEMBL5668586 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E | |
| Phthalic Acid SCHEMBL146125 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E | |
| Phthalic Acid SCHEMBL1808 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E | |
| Phthalic Acid SCHEMBL1332278 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E | |
| Phthalic Acid SCHEMBL4452470 | 0.80 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAPTPOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4250063-A | COORDINATION CATALYST COMPRISING AN ORGANIC COMPLEX OF TUNGSTEN OR MOLYBDENUM, A TITANIUM TETRAHALIDE, AND AN N-HALO IMIDE, A SULFIDE, A SULFOXIDE, OR A PHOSPHINE; POLYALKENAMERS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-02-10 | — | — | US | claimed |
| US-4233459-A | TREATED WITH REDUCING AGENTS IN TWO STEPS DURING OR AFTER PREPARATION FROM ALKALI METAL PHTHALAMATE OR PHTHALIMIDATE AND AN ALKALI METAL HYPOHALITE | BASF AKTIENGESELLSCHAFT (DE) | 1980-11-11 | — | — | US | claimed |
| CN-119874611-A | Process for preparing benzyl 4-amino-3-chloro-5-fluoro-6- (4-chloro-2-fluoro-3-methoxyphenyl) picolinate | 科迪华农业科技有限责任公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-110088107-A | Compounds, compositions and uses thereof | 赛诺维信制药公司 | 2019-08-02 | — | — | CN | disclosed |
| US-8779137-B2 | Compound and organic electroluminescent element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-15 | — | — | US | disclosed |
| US-20120286654-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-11-15 | — | — | US | disclosed |
| EP-2520576-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-20110114185-A1 | PHOTOELECTRIC CONVERSION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-19 | — | — | US | disclosed |
| EP-0054677-A2 | Cephalosporins, process for their preparation and pharmaceutical compositions containing them | Dr. Karl Thomae GmbH (DE) | 1982-06-30 | — | — | EP | disclosed |
| EP-0004635-B1 | PROCESS FOR THE CONTINUOUS PREPARATION OF ANTHRANILIC ACID | BASF Aktiengesellschaft (DE) | 1981-08-12 | — | — | EP | disclosed |
| US-4276433-A | Continuous preparation of anthranilic acid | BASF AKTIENGESELLSCHAFT (DE) | 1981-06-30 | — | — | US | disclosed |
| US-4250063-A | COORDINATION CATALYST COMPRISING AN ORGANIC COMPLEX OF TUNGSTEN OR MOLYBDENUM, A TITANIUM TETRAHALIDE, AND AN N-HALO IMIDE, A SULFIDE, A SULFOXIDE, OR A PHOSPHINE; POLYALKENAMERS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-02-10 | — | — | US | disclosed |
| EP-0003053-B1 | PROCESS FOR THE CONTINUOUS PREPARATION OF ANTHRANILIC ACID | BASF Aktiengesellschaft (DE) | 1980-11-26 | — | — | EP | disclosed |
| US-4233459-A | TREATED WITH REDUCING AGENTS IN TWO STEPS DURING OR AFTER PREPARATION FROM ALKALI METAL PHTHALAMATE OR PHTHALIMIDATE AND AN ALKALI METAL HYPOHALITE | BASF AKTIENGESELLSCHAFT (DE) | 1980-11-11 | — | — | US | disclosed |
| EP-0004635-A2 | Process for the continuous preparation of anthranilic acid | BASF Aktiengesellschaft (DE) | 1979-10-17 | — | — | EP | disclosed |
| EP-0003053-A1 | Process for the continuous preparation of anthranilic acid | BASF Aktiengesellschaft (DE) | 1979-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120286654-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | ETV6, RPL19, LEF1 | ALDH1A1 1210/4885ALOX15 206/4885KMT2A 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.